Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-09 Sale(A) |
2022-05-27 4:20 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
159,177 | $16 | $2,546,832 | 1,439,525 (Direct) |
View |
2022-05-25 Purchase |
2022-05-27 4:18 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
11,313 | $1.2466 | $14,103 | 1,891,947 (Direct) |
View |
2022-05-20 Purchase |
2022-05-25 5:58 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
82,200 | $1.2339 | $101,428 | 1,721,457 (Direct) |
View |
2021-12-27 Purchase |
2021-12-29 4:08 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
277,244 | $2.6344 | $730,373 | 1,639,257 (Direct) |
View |
2021-12-20 Purchase |
2021-12-22 4:06 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
3,527 | $2.5449 | $8,976 | 1,362,013 (Direct) |
View |
2021-12-16 Purchase |
2021-12-20 6:44 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
41,625 | $2.5454 | $105,951 | 1,358,486 (Direct) |
View |
2021-12-15 Purchase |
2021-12-17 5:13 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
77,604 | $2.4091 | $186,956 | 1,316,861 (Direct) |
View |
2021-09-17 Sale |
2021-09-21 5:14 pm |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
400,000 | $9.4 | $3,760,000 | 2,856,309 (Indirect Direct) |
View |
2021-02-09 Sale |
2021-02-11 7:25 pm |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
159,177 | $16 | $2,546,832 | 1,280,348 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-08 Option Award |
2025-04-10 4:03 pm |
2025-04-08 N/A |
Serina Therapeutics Inc. | SER | Venkatesan Jay Director |
96,525 | $5.18 | 96,525 (Indirect) |
View |
2025-02-12 Option Award |
2025-02-13 5:03 pm |
N/A 2035-02-12 |
Serina Therapeutics Inc. | SER | Venkatesan Jay Director |
40,000 | $0 | 40,000 (Direct) |
View |
2024-11-26 Exercise |
2024-11-29 07:39 am |
2024-07-01 N/A |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
50,000 | $0 | 180,534 (Direct) |
View |
2024-11-26 Exercise |
2024-11-29 07:39 am |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
50,000 | $0.01 | 180,534 (Direct) |
View |
2024-11-21 Option Award |
2024-11-25 07:35 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
4,100 | $0 | 4,100 (Direct) |
View |
2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
4,100 | $0 | 4,100 (Direct) |
View |
2022-07-15 Exercise |
2022-07-19 4:38 pm |
N/A 2025-12-15 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
20,063 | $0.45 | 2,946,372 (Direct) |
View |
2021-02-09 Conversion(A) |
2022-05-27 4:20 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
262 | $11.57 | 1,439,525 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:20 pm |
N/A 2028-07-05 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
396,329 | $0 | 1,439,525 (Direct) |
View |
2021-02-09 Exercise(A) |
2022-05-27 4:20 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
396,329 | $6.43 | 1,439,525 (Direct) |
View |
2022-03-03 Option Award |
2022-03-04 4:22 pm |
N/A 2032-03-02 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
760,000 | $0 | 1,360,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-04 5:37 pm |
N/A 2032-01-02 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-24 Tax Withholding |
2021-12-17 5:13 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
41,091 | $13.78 | 1,316,861 (Direct) |
View |
2021-03-30 Exercise |
2021-04-23 6:14 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
7,650 | $4.09 | 3,256,309 (Direct) |
View |
2021-03-30 Exercise |
2021-04-23 6:14 pm |
N/A 2029-01-01 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
15,300 | $0 | 3,256,309 (Direct) |
View |
2021-03-31 Exercise |
2021-04-23 6:14 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
7,650 | $3.6233 | 3,256,309 (Direct) |
View |
2021-02-09 Conversion |
2021-02-11 7:25 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
170,037 | $0 | 1,280,348 (Direct) |
View |
2021-02-09 Conversion |
2021-02-11 7:25 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
262 | $11.57 | 1,280,348 (Direct) |
View |
2021-02-09 Tax Withholding |
2021-02-11 7:25 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
31,966 | $16 | 1,280,348 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 7:25 pm |
N/A 2028-07-05 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
237,152 | $0 | 1,280,348 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 7:25 pm |
N/A N/A |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
237,152 | $6.43 | 1,280,348 (Direct) |
View |
2021-02-04 Option Award |
2021-02-08 12:57 pm |
N/A 2031-02-03 |
Angion Biomedica Corp. | ANGN | Venkatesan Jay See Remarks |
178,920 | $0 | 178,920 (Direct) |
View |
Ownership |
2021-02-04 5:31 pm |
N/A N/A |
Angion Biomedica Corp. | ANG | Venkatesan Jay See Remarks |
0 | $0 | 2,638,158 (Direct) |
View |
2021-01-04 Option Award |
2021-01-05 7:03 pm |
N/A 2031-01-03 |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
7,650 | $0 | 7,650 (Direct) |
View |
2020-12-22 Other |
2020-12-22 5:30 pm |
N/A N/A |
ALPINE IMMUNE SCIENCES INC. | ALPN | Venkatesan Jay Director 10% Owner |
1,174,825 | $0 | 4,415,834 (Indirect) |
View |
2020-07-06 Exercise |
2020-07-08 4:46 pm |
N/A N/A |
EXICURE INC. | XCUR | Venkatesan Jay Director |
9,310 | $0.65 | 672,288 (Direct) |
View |
2020-07-06 Exercise |
2020-07-08 4:46 pm |
N/A 2024-02-17 |
EXICURE INC. | XCUR | Venkatesan Jay Director |
22,240 | $0 | 672,288 (Direct) |
View |
2020-07-06 Exercise |
2020-07-08 4:46 pm |
N/A N/A |
EXICURE INC. | XCUR | Venkatesan Jay Director |
12,930 | $1.03 | 672,288 (Direct) |
View |
2020-06-04 Option Award |
2020-06-08 7:22 pm |
N/A 2030-06-03 |
EXICURE INC. | XCUR | Venkatesan Jay Director |
21,693 | $0 | 21,693 (Direct) |
View |